• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Type 2 Diabetes Mellitus Treatment Companies

    ID: MRFR/Pharma/4214-HCR
    85 Pages
    Rahul Gotadki
    September 2025

    Companies involved in the treatment of Type 2 Diabetes Mellitus (T2DM) cover a broad spectrum, including pharmaceuticals, medical devices, and healthcare services.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Type 2 Diabetes Mellitus Treatment Market

    Type 2 Diabetes Mellitus Treatment Key Companies

     

    Latest Type 2 Diabetes Mellitus Treatment Companies Update


    Eli Lilly Announced positive Phase 3 trial results for its GLP-1 receptor agonist Tirzepatide, demonstrating superior blood sugar control and weight loss compared to existing drugs.


    Novo Nordisk Received FDA approval for its dual SGLT2/GLP-1 agonist Ozempic®, offering a new option for patients with inadequate glycemic control on other medications.


    Boehringer Ingelheim Partnered with Eli Lilly to co-develop and commercialize their next-generation SGLT2 inhibitor Jardiance®, aiming to expand their reach in the diabetes market.


    List of Type 2 Diabetes Mellitus Treatment Key Companies in the Market



    • Abbott Laboratories

    • Acon Laboratories Inc.

    • Adocia

    • Akros Pharma

    • Amgen

    • AstraZeneca

    • Bayer AG

    • Becton

    • Dickinson and Company

    • Biocon

    • Boehringer Ingelheim

    • Daiichi Sankyo

    • Eli Lilly

    • Merck

    • Novartis & Co.

    • Novo Nordisk

    • Peptron

    • Pfizer

    • Roche Diagnostics Ltd.

    • Sanofi

    • Sunpharma

    • Takeda Pharmaceuticals